Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling,and inhibits migration and invasion Sarah E. Golding,Elizabeth Rosenberg,et al. Mol Cancer Ther 2009 October;8(10): 2894–2902
The pharmacological and toxicological properties of this product have not been fully investigated. Exercise caution in use and handling. This product must not be used in humans.